FDA Clears Box DICOM Viewer as Class II Medical Device

Article

The FDA has cleared Box DICOM Viewer, part of the Box for Healthcare solution.

Box has received FDA clearance for its DICOM Viewer, the company announced at HIMSS 2016.

Box, an enterprise content management platform, developed a solution tailored for hospitals that streamlines referral management, enables medical professionals to share and view DICOM files, and provides access to critical data that is often “trapped in proprietary hospital-based enterprise systems,” a release said.

The Box DICOM viewer is part of the Box for Healthcare solution, which includes a content management platform that allows hospitals to securely share and manage content in the cloud from any device in real time; Box Governance, which enables customers to comply with regulatory policies, satisfy e-discovery requests, and manage sensitive information; Box Consulting Services, which provides expertise to help customers transform their clinical workflows with custom integration; and Partner Integration Capabilities, which supports HIPAA-compliant faxing services and communication with hospital based record systems, the company said.

The Box DICOM Viewer is now generally available and has been FDA cleared as a Class II Medical Device, and can therefore be used for diagnostic purposes.[[{"type":"media","view_mode":"media_crop","fid":"46782","attributes":{"alt":"Box DICOM Viewer","class":"media-image","id":"media_crop_3507474655434","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"5454","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":"Image courtesy of Box.","typeof":"foaf:Image"}}]]

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.